Salute e Benessere
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers
Currently, six distinguished service provider laboratories have received CSP certification to date and are actively accepting projects, including:
"We are thrilled to launch the Certified Service Provider Program to make our NULISA technology more accessible to the research community," said Yuling Luo , Ph.D., Founder, Chairman and CEO of Alamar Biosciences. "By collaborating with these trusted service providers, we are ensuring that researchers have the support and expertise they need to drive groundbreaking discoveries in protein biomarker research."
The CSP Program represents a significant milestone in Alamar's goal to accelerate scientific advancements through innovative assay solutions. Researchers can now engage with certified partners to execute their projects with confidence, knowing they are working with labs that meet Alamar's rigorous standards for quality and performance.
Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA™ Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.
Video - https://www.youtube.com/watch?v=9KcTXmAWCdc
Logo - https://mma.prnewswire.com/media/1810182/Alamar_Logo_WhiteOutline_RGB_4x1_Logo_V1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/alamar-biosciences-launches-certified-service-provider-program-to-expand-access-to-nulisa-technology-for-academic-and-biopharmaceutical-researchers-302381942.html